You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 9, 2025

Drug Price Trends for cardizem la


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for cardizem la

Average Pharmacy Cost for cardizem la

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CARDIZEM LA 120 MG TABLET 00187-2045-30 3.65828 EACH 2024-12-18
CARDIZEM LA 240 MG TABLET 00187-2047-30 4.34239 EACH 2024-12-18
CARDIZEM LA 120 MG TABLET 00187-2045-90 3.65828 EACH 2024-12-18
CARDIZEM LA 240 MG TABLET 00187-2047-90 4.34239 EACH 2024-12-18
CARDIZEM LA 120 MG TABLET 00187-2045-30 3.66533 EACH 2024-11-20
CARDIZEM LA 120 MG TABLET 00187-2045-90 3.66533 EACH 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Cardizem la Market Analysis and Financial Projection

Market Analysis and Price Projections for Cardizem LA (Diltiazem)

Market Overview

Cardizem LA, a formulation of the calcium channel blocker diltiazem, is a crucial medication for managing hypertension, angina, and certain heart rhythm disorders. Here’s a comprehensive analysis of the market trends, drivers, and price projections for Cardizem LA.

Market Size and Growth

The global diltiazem market, which includes Cardizem LA, is projected to experience significant growth. By 2028, the market is expected to reach US$ 832.51 million from US$ 369.95 million in 2021, growing at a Compound Annual Growth Rate (CAGR) of 12.3% from 2021 to 2028[1].

In North America specifically, the diltiazem market was valued at US$ 161.53 million in 2021 and is projected to reach US$ 369.22 million by 2028, with a CAGR of 12.5% during the same period[3].

Key Drivers

Increase in Cardiovascular Disease Incidence

The rising incidence of cardiovascular diseases, particularly among the elderly population, is a major driver for the diltiazem market. Cardiovascular diseases such as hypertension, angina, and atrial fibrillation are more prevalent in older adults due to structural and functional changes in the cardiovascular system associated with aging[1][3].

Increasing Elderly Population

The global elderly population is growing, and this demographic is more prone to cardiovascular diseases. This demographic shift is expected to bolster the demand for diltiazem and other cardiovascular medications[1][3].

Government Initiatives and Healthcare Policies

Government initiatives aimed at promoting healthcare and managing chronic diseases also contribute to the market growth. These initiatives often include programs to increase awareness and access to treatments for cardiovascular diseases[3].

Market Segments

Product Type

The diltiazem market is segmented into capsules, injections, and tablets. In 2021, the tablets segment, which includes Cardizem LA, held the largest share of the market. However, the capsules segment is expected to witness the fastest CAGR during the forecast period[1][3].

Application

The market is also segmented by application, with hypertension being the largest segment in 2021. The angina segment is expected to grow at the fastest CAGR in the coming years[1][3].

Price Projections and Cost Analysis

Current Pricing

The cost for Cardizem LA (diltiazem) varies based on the dosage and quantity. For example, a supply of 30 tablets of Cardizem LA 120 mg/24 hours can cost around $130, while a generic version can be significantly cheaper, starting from $81.31 for 30 tablets[2].

Here is a breakdown of the prices for different dosages:

  • 120 mg/24 hours: Around $129.67 for 30 tablets
  • 180 mg/24 hours: Around $136.46 for 30 tablets
  • 240 mg/24 hours: Around $151.80 for 30 tablets
  • 300 mg/24 hours: Around $194.63 for 30 tablets
  • 360 mg/24 hours: Around $208.53 for 30 tablets
  • 420 mg/24 hours: Around $225.20 for 30 tablets[2].

Discounts and Patient Assistance Programs

Patients can benefit from various discount programs, copay cards, and patient assistance programs. For instance, the Drugs.com Discount Card can save up to 80% on prescription medicines. Additionally, programs like the HealthWell Foundation Copay Program provide financial assistance for eligible individuals to cover coinsurance, copayments, and healthcare premiums[2][5].

Challenges and Restraints

Side Effects of Diltiazem

Despite the growing demand, the market is likely to be hampered by the side effects associated with diltiazem. Common side effects include dizziness, headache, and swelling, which can deter some patients from using the medication[1][3].

Regional Insights

The diltiazem market is analyzed across various regions, including North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. North America is expected to be a significant market due to the high prevalence of cardiovascular diseases and the presence of major pharmaceutical companies[1][3].

Key Players

The diltiazem market includes major players such as Bausch Health, Teva Pharmaceutical Industries Ltd, Mylan N.V, Athenex, Pfizer, Inc, Glenmark, Sandoz (Novartis Ag), Sun Pharmaceutical Company Ltd, Hikma Pharmaceuticals, and Zydus Pharmaceuticals. These companies focus on product innovations and strategic marketing to maintain their market share[1].

Mechanism of Action and Clinical Use

Diltiazem works by reducing intracellular calcium concentrations, leading to smooth muscle relaxation, arterial vasodilation, and decreased blood pressure. It is particularly useful for heart rate control in patients with atrial fibrillation and for managing chronic stable angina and hypertension[4].

"Diltiazem causes a reduction in the contractile processes of the myocardial smooth muscle cells and vasodilation of the coronary and systemic arteries, including epicardial and subendocardial. This subsequently leads to increased oxygen delivery to the myocardial tissue, improved cardiac output due to increased stroke volume, decreased total peripheral resistance, decreased systemic blood pressure and heart rate, and decreased afterload."[4]

Future Trends

The market is expected to see recent developments in product formulations and delivery systems. Pharmaceutical companies are focusing on improving patient compliance and reducing side effects through innovative formulations. Additionally, the impact of the COVID-19 pandemic has accelerated the development of new treatments and vaccines, which could positively influence the diltiazem market[3].

Key Takeaways

  • The global diltiazem market, including Cardizem LA, is projected to grow significantly due to the increasing incidence of cardiovascular diseases and the growing elderly population.
  • The market is segmented by product type and application, with tablets being the dominant segment and hypertension being the largest application segment.
  • Prices for Cardizem LA vary based on dosage and quantity, with generic versions offering significant cost savings.
  • Patient assistance programs and discount cards are available to help reduce the financial burden on patients.
  • Side effects of diltiazem remain a challenge for market growth.

Frequently Asked Questions (FAQs)

1. What is Cardizem LA used for?

Cardizem LA (diltiazem) is used to treat hypertension, manage chronic stable angina, and control heart rate in patients with atrial fibrillation.

2. How does diltiazem work?

Diltiazem works by reducing intracellular calcium concentrations, leading to smooth muscle relaxation, arterial vasodilation, and decreased blood pressure.

3. What are the common side effects of diltiazem?

Common side effects include dizziness, headache, and swelling.

4. How much does Cardizem LA cost?

The cost for Cardizem LA varies based on dosage and quantity, but a supply of 30 tablets of the 120 mg/24 hours formulation can cost around $130, with generic versions starting from $81.31.

5. Are there any patient assistance programs available for Cardizem LA?

Yes, there are patient assistance programs, discount cards, and copay programs available to help reduce the cost of Cardizem LA for eligible patients.

Cited Sources:

  1. The Insight Partners. Diltiazem Market Size, Share & Growth Analysis by 2028.
  2. Drugs.com. Cardizem LA Prices, Coupons, Copay Cards & Patient Assistance.
  3. Business Market Insights. North America Diltiazem Market report 2028.
  4. DrugBank Online. Diltiazem: Uses, Interactions, Mechanism of Action.
  5. Drugs.com. Cardizem Prices, Coupons, Copay Cards & Patient Assistance.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.